ANG Lifesciences India Limited, originally incorporated in 2006, is a pharmaceutical company specializing in the manufacturing and marketing of sterile dry powder injection vials. With its commercial production beginning in 2008-09 and direct sales launching in 2014-15, the company has established itself in both domestic and international markets, including Africa and the Gulf countries. ANG Lifesciences operates four state-of-the-art formulation plants in Baddi, Himachal Pradesh, which adhere to ISO-9001:2008 and GMP standards, ensuring high-quality production.
In 2017, the company raised Rs 12 crore through a public issue of equity shares to expand its operations. The acquisition of Mansa Printers & Publishers Limited in 2021 further demonstrates its strategic approach for backward integration, optimizing costs, and ensuring a steady supply of packaging materials. This move enhances its production efficiency and supports its geographical expansion strategy.
